J&J | JNJ - Gross Profit On Sales

Stock Price
231.73
Daily Change
2.41 1.05%
Monthly
2.49%
Yearly
51.84%
Q2 Forecast
222.15

J&J reported $17.24B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AbbVie USD 12.54B 474M Mar/2026
Abbott USD 5.86B 675M Mar/2026
Amgen USD 6.89B 415M Dec/2025
AstraZeneca USD 12.61B 225M Mar/2026
Baxter International USD 891M 314M Mar/2026
Bayer EUR 6.94B 1.58B Dec/2025
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Biogen USD 1.82B 169.5M Mar/2026
Boston Scientific USD 3.61B 64M Mar/2026
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
CONMED USD 183.45M 34.84M Mar/2026
Cooper Companies USD 695.2M 44.4M Dec/2025
Dexcom USD 750.3M 42.4M Mar/2026
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Eli Lilly USD 15.92B 1.33B Dec/2025
Gilead Sciences USD 5.52B 791M Mar/2026
GlaxoSmithKline GBP 5.75B 429M Mar/2026
Globus Medical USD 496.26M 39.69M Mar/2026
Insulet USD 540.8M 27.8M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
J&J USD 17.24B 642M Mar/2026
Medtronic USD 5.41B 27M Dec/2025
Merck USD 10.85B 2.57B Dec/2025
Merit Medical Systems USD 184.8M 10.56M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Pfizer USD 11.04B 1.24B Mar/2026
Regeneron Pharmaceuticals USD 2.94B 363.7M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Stryker USD 3.81B 675M Mar/2026
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teva Pharmaceutical Industries USD 2.11B 547M Mar/2026
Vertex Pharmaceuticals USD 2.6B 121.7M Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025
Zoetis USD 1.62B 20M Mar/2026